25 Nov 2013 10:47
25 November 2013
Toumaz Limited
Result of Extraordinary General Meeting
Toumaz Limited (AIM: TMZ, "Toumaz" or the "Company"), a pioneer in low-power wireless semiconductor and software technologies, is pleased to announcethat the ordinary resolution proposed to the Company's shareholders at the Extraordinary General Meeting held earlier today was duly passed.
The placing announced on 7 November 2013 (the "Announcement") to raise £17.7 million before expenses is now only conditional on admission of the placing shares to trading on AIM.
Application has been made to the London Stock Exchange for the 442,500,000 Placing Shares to be so admitted. Trading in the Placing Shares is expected to commence at 8.00 a.m. on 26 November 2013. Following admission, there will be 1,591,052,100 ordinary shares in issue and admitted to trading on AIM.
Words and expressions in this announcement have (unless the context otherwise admits) the same meaning as in the Announcement.
Enquiries:
Toumaz Limited | +44 (0)20 7391 0630 |
Anthony Sethill, Chief Executive Officer | |
Jonathan Apps, Chief Financial Officer | |
Peel Hunt LLP (Nominated Adviser and Broker) | +44 (0)20 7418 8900 |
Richard Kauffer Daniel Harris Matthew Brooke-Hitching | |
Vijay Barathan (Healthcare & Life Sciences) | |
College Hill | +44 (0)20 7457 2056 |
Adrian Duffield/Rozi Morris |
About Toumaz (www.toumaz.com)
Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The Company has two divisions, Toumaz Healthcare and Frontier Silicon. Toumaz Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chip, modules and software for digital radio and connected audio devices.